170 related articles for article (PubMed ID: 16540107)
1. Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.
Dunbar SA; Karamian I; Yeatman A; Zhang J
Eur J Pharmacol; 2006 Mar; 535(1-3):152-6. PubMed ID: 16540107
[TBL] [Abstract][Full Text] [Related]
2. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
3. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
4. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
Gu G; Kondo I; Hua XY; Yaksh TL
J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
[TBL] [Abstract][Full Text] [Related]
5. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
[TBL] [Abstract][Full Text] [Related]
8. Periodic abstinence enhances nociception without significantly altering the antinociceptive efficacy of spinal morphine in the rat.
Dunbar SA; Karamian IG
Neurosci Lett; 2003 Jul; 344(3):145-8. PubMed ID: 12812826
[TBL] [Abstract][Full Text] [Related]
9. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
Smith CG; Bowery NG; Whitehead KJ
Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
[TBL] [Abstract][Full Text] [Related]
10. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
11. The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla.
Schepers RJ; Mahoney JL; Zapata A; Chefer V; Shippenberg TS
J Neurochem; 2008 Feb; 104(3):806-17. PubMed ID: 17961151
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
[TBL] [Abstract][Full Text] [Related]
13. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats.
Tai YH; Wang YH; Wang JJ; Tao PL; Tung CS; Wong CS
Pain; 2006 Sep; 124(1-2):77-86. PubMed ID: 16697108
[TBL] [Abstract][Full Text] [Related]
14. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
Beani L; Tanganelli S; Antonelli T; Simonato M; Spalluto P; Tomasini C; Bianchi C
J Pharmacol Exp Ther; 1989 Aug; 250(2):682-7. PubMed ID: 2547945
[TBL] [Abstract][Full Text] [Related]
15. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
[TBL] [Abstract][Full Text] [Related]
16. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
18. Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal.
Trang T; Sutak M; Quirion R; Jhamandas K
Br J Pharmacol; 2003 Sep; 140(2):295-304. PubMed ID: 12970109
[TBL] [Abstract][Full Text] [Related]
19. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
20. Effect of morphine on the release of excitatory amino acids in the rat hind instep: Pain is modulated by the interaction between the peripheral opioid and glutamate systems.
Jin YH; Nishioka H; Wakabayashi K; Fujita T; Yonehara N
Neuroscience; 2006; 138(4):1329-39. PubMed ID: 16473472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
